Thrombosis from a prothrombin mutation conveying antithrombin resistance

  • MIYAWAKI Y
N/ACitations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

We identified a novel mechanism of hereditary thrombosis associated with antithrombin resistance, with a substitution of arginine for leucine at position 596 (p.Arg596Leu) in the gene encoding prothrombin (called prothrombin Yukuhashi). The mutant prothrombin had moderately lower activity than wild-type prothrombin in clotting assays, but the formation of thrombin-antithrombin complex was substantially impaired. A thrombin-generation assay revealed that the peak activity of the mutant prothrombin was fairly low, but its inactivation was extremely slow in reconstituted plasma. The Leu596 substitution caused a gain-of-function mutation in the prothrombin gene, resulting in resistance to antithrombin and susceptibility to thrombosis. Copyright © 2012 Massachusetts Medical Society. All rights reserved.

Cite

CITATION STYLE

APA

MIYAWAKI, Y. (2013). Thrombosis from a prothrombin mutation conveying antithrombin resistance. Japanese Journal of Thrombosis and Hemostasis, 24(4), 402–406. https://doi.org/10.2491/jjsth.24.402

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free